Guideline / position statementindependent cross-checkfull text checked★ key study I-INS-131 in-depth review
US diabetes standards 2026: children and adolescents
14. Children and Adolescents: Standards of Care in Diabetes-2026.
Overview
American Diabetes Association Professional Practice Committee for Diabetes. Diabetes Care 2026 · PMID 41358890 · DOI 10.2337/dc26-S014
Insulin is essential for children with type 1 diabetes; in youth with type 2 diabetes, insulin can be reduced when goals are met.
Does the study support the specific claim? No · Methodological quality: high
Plain-language summary
Study explained simply
- What did the researchers want to find out?
Guide paediatric diabetes care.
- How was the study done?
Evidence-graded guideline.
- How many people, animals or samples were studied?
Not applicable.
- What was actually found?
Insulin paramount in T1D; insulin for ketoacidosis.
- How large was the observed effect?
Not applicable.
- What do the results mean in everyday life?
Children with type 1 diabetes need insulin.
- What are the study's limitations?
Guideline.
- What does it say about Elawady's specific claim?
- Do the results apply to Germany and Europe?
European paediatric guidance (ISPAD, NICE NG18) agrees.
- What can explicitly not be concluded from this study?
Not applicable.
Scientific in-depth review
1. Full reference
- Authors
- American Diabetes Association Professional Practice Committee for Diabetes
- Journal
- Diabetes Care
- Year
- 2026
- Identifier
- PMID 41358890 DOI 10.2337/dc26-S014
- Verification
- verified – PubMed efetch 2026-10-26; Crossref 2026-10-26; full text read at the PMC URL
- Retracted
- no
- Corrections
- none
- Extent checked
- full text
- Conflicts of interest and funding
ADA.
2. Research question
How should diabetes in children and adolescents be managed?
3. Study design and population
- Study design
- Guideline / position statement – Clinical practice guideline (ADA Standards of Care, section 14)
- Population
Children and adolescents with diabetes
- Country
USA (international use)
- Period
2026
- Sample size
Not applicable
- Inclusion and exclusion criteria
Not applicable
4. Methods and endpoints
- Exposure / intervention
Not applicable
- Comparator
Not applicable
- Endpoints
Recommendations
- Statistical methods
Not applicable
5. Actual results
- Results
'For those with type 1 diabetes, insulin therapy is paramount'. Thyroid function screening recommended because autoimmune thyroid disease accompanies T1D. Rec 14.36 (A): initiate insulin in individuals with ketoacidosis. For youth-onset type 2 diabetes: rec 14.39 consider maximising non-insulin therapies before initiating/intensifying insulin; rec 14.40 consider reducing or discontinuing insulin when glucose goals are met.
- Absolute risks
not applicable
- Authors' conclusion
Insulin is paramount in paediatric T1D.
6. Strengths
- Current, evidence-graded recommendations
7. Weaknesses
- Consensus elements; partly expert opinion
8. Risk of bias
- Orienting tool
- none applicable
- Type of assessment
- simplified assessment (abstract only)
- Full formal assessment
- no
- Overall risk of bias
- not assessable
- Rationale
Guideline; graded recommendations from systematic evidence review.
9. Assessment of the statistical interpretation
Not applicable
10. Relevance to the specific claim
Contradicts 'insulin before puberty is a catastrophe'; thyroid disease is screened for because it is associated with T1D autoimmunity, not caused by insulin; supports careful insulin reduction in youth T2D (archive position).
11. Independent contrary findings
12. Transferability to Germany and Europe
Directly applicable; same biology and clinical standards in Europe.
13. Overall methodological judgement
Current authoritative guideline.
| Multidimensional assessment | |
|---|---|
| Authenticity of the source | verified |
| Methodological quality | high |
| Risk of bias | not assessable |
| Precision of results | not applicable |
| Directness | direct |
| Reproducibility | unknown |
| Consistency with the overall evidence | consistent |
| Regional transferability | high |
| Adequacy of the interpretation (by the archive) | not applicable |
14. Open questions
15. Linked fact checks
- There is no such thing as type 1 diabetes; 'type 1' is a state of high sugar seen mainly in athletes with high needs; type 1 patients do not develop complications; insulin before puberty is a catastrophe (short stature, thyroid problems, cysts). – Studies contradicting or limiting the claim
- Archive conclusion: insulin is indispensable in type 1 diabetes; in type 2 diabetes, evidence supports caution with intensive dosing, prioritising metformin, weight loss and dietary change before insulin escalation, and aiming for moderate rather than near-normal HbA1c; this is not the same as rejecting insulin. – Studies supporting the claim